• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国肥胖症与减重手术的流行病学和趋势。

Epidemiology and Trends of Obesity and Bariatric Surgery in Korea.

机构信息

Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.

Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Endocrinol Metab (Seoul). 2024 Oct;39(5):678-685. doi: 10.3803/EnM.2024.2056. Epub 2024 Aug 2.

DOI:10.3803/EnM.2024.2056
PMID:39090817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11525690/
Abstract

The prevalence of obesity in Korea has steadily increased over the past decade, reaching 38.4% in 2021. Notably, the rate of class II- III obesity, defined as a body mass index (BMI) of 30 kg/m2 or higher, exceeded 7% in the same year. Since January 2019, the National Health Insurance Service (NHIS) has provided coverage for bariatric surgery (BS) for eligible patients. Coverage is available for individuals with a BMI of 35 kg/m2 or higher, or those with a BMI of 30 kg/m2 or higher who also have obesity-related comorbidities. Additionally, partial reimbursement is offered for BS in patients with type 2 diabetes mellitus who have BMI values between 27.5 and 30 kg/m2. From 2019 to 2022, the NHIS recorded 9,080 BS procedures, with sleeve gastrectomy being the most commonly performed. The average percentage of weight loss 198±99.7 days post-surgery was 17.9%, with 80.0% of patients losing more than 10% of their body weight. This article presents the trends in obesity and BS in Korea.

摘要

在过去的十年中,韩国的肥胖患病率稳步上升,2021 年达到 38.4%。值得注意的是,同年,二类和三类肥胖(BMI 指数达到 30kg/m2 或更高)的发生率超过了 7%。自 2019 年 1 月起,国家健康保险服务(NHIS)开始为符合条件的患者提供减重手术(BS)的保险。该保险覆盖 BMI 指数达到 35kg/m2 或更高的人群,或 BMI 指数达到 30kg/m2 或更高且患有肥胖相关合并症的人群。此外,对于 BMI 值在 27.5 到 30kg/m2 之间的 2 型糖尿病患者,BS 也可获得部分报销。2019 年至 2022 年,NHIS 共记录了 9080 例 BS 手术,其中最常见的是袖状胃切除术。术后 198±99.7 天的平均减重百分比为 17.9%,80.0%的患者体重减轻超过 10%。本文介绍了韩国肥胖和 BS 的趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798a/11525690/fb629cb76143/enm-2024-2056f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798a/11525690/3623e62edf6b/enm-2024-2056f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798a/11525690/52aa91c8a9bb/enm-2024-2056f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798a/11525690/fb629cb76143/enm-2024-2056f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798a/11525690/3623e62edf6b/enm-2024-2056f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798a/11525690/52aa91c8a9bb/enm-2024-2056f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798a/11525690/fb629cb76143/enm-2024-2056f3.jpg

相似文献

1
Epidemiology and Trends of Obesity and Bariatric Surgery in Korea.韩国肥胖症与减重手术的流行病学和趋势。
Endocrinol Metab (Seoul). 2024 Oct;39(5):678-685. doi: 10.3803/EnM.2024.2056. Epub 2024 Aug 2.
2
Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses.肥胖症手术治疗 2 型糖尿病合并胰岛素治疗患者:临床结果和成本效益分析。
PLoS Med. 2020 Dec 7;17(12):e1003228. doi: 10.1371/journal.pmed.1003228. eCollection 2020 Dec.
3
Cost-effectiveness of Bariatric Surgery for People with Morbid Obesity in South Korea.韩国病态肥胖人群行减肥手术的成本效益分析。
Obes Surg. 2020 Jan;30(1):256-266. doi: 10.1007/s11695-019-04122-w.
4
Effects of Bariatric Surgery on Sarcopenic Obesity Outcomes: A One-Year Prospective Study in Middle-Aged Women.减重手术对肌肉减少性肥胖结局的影响:一项中年女性为期一年的前瞻性研究。
Obes Surg. 2024 May;34(5):1674-1683. doi: 10.1007/s11695-024-07164-x. Epub 2024 Mar 25.
5
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
6
Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation.轻度至中度肥胖的减肥手术:系统评价和经济评估。
Obes Surg. 2012 Sep;22(9):1496-506. doi: 10.1007/s11695-012-0679-z.
7
A Landscape of Bariatric Surgery in Canada: For the Treatment of Obesity, Type 2 Diabetes and Other Comorbidities in Adults.加拿大减重手术全景:治疗成人肥胖、2 型糖尿病和其他合并症。
Can J Diabetes. 2018 Oct;42(5):560-567. doi: 10.1016/j.jcjd.2017.12.007. Epub 2017 Dec 12.
8
[From bariatric to metabolic surgery: 15 years experience in a French university hospital].[从减重手术到代谢手术:法国一家大学医院的15年经验]
Bull Acad Natl Med. 2010 Jan;194(1):25-36; discussion 36-8.
9
Incidence and Risk Factors for Cholelithiasis After Bariatric Surgery.减肥手术后胆石症的发病率及危险因素
Obes Surg. 2019 Jul;29(7):2110-2114. doi: 10.1007/s11695-019-03760-4.
10
Population estimates and characteristics of Australians potentially eligible for bariatric surgery: findings from the 2011-13 Australian Health Survey.澳大利亚可能符合减肥手术条件人群的估计数量及特征:来自2011 - 2013年澳大利亚健康调查的结果
Aust Health Rev. 2018 Aug;42(4):429-437. doi: 10.1071/AH16255.

引用本文的文献

1
Long-term exposure to ambient air pollutant mixture and metabolic obesity phenotypes: Results from a nationwide Korean study (2007-2019).长期暴露于环境空气污染物混合物与代谢性肥胖表型:一项韩国全国性研究(2007 - 2019年)的结果
J Expo Sci Environ Epidemiol. 2025 Jul 11. doi: 10.1038/s41370-025-00789-9.

本文引用的文献

1
2023 Obesity Fact Sheet: Prevalence of Obesity and Abdominal Obesity in Adults, Adolescents, and Children in Korea from 2012 to 2021.《2023年肥胖情况说明书:2012年至2021年韩国成年人、青少年和儿童的肥胖及腹部肥胖患病率》
J Obes Metab Syndr. 2024 Mar 30;33(1):27-35. doi: 10.7570/jomes24012. Epub 2024 Mar 27.
2
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.2023 年韩国糖尿病协会糖尿病临床实践指南。
Diabetes Metab J. 2023 Sep;47(5):575-594. doi: 10.4093/dmj.2023.0282. Epub 2023 Sep 26.
3
Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity.
肥胖症的诊断:韩国肥胖研究学会《2022年肥胖症临床实践指南更新》
J Obes Metab Syndr. 2023 Jun 30;32(2):121-129. doi: 10.7570/jomes23031.
4
Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity.肥胖症及其合并症的评估与治疗:韩国肥胖研究学会2022年肥胖临床实践指南更新
J Obes Metab Syndr. 2023 Mar 30;32(1):1-24. doi: 10.7570/jomes23016. Epub 2023 Mar 22.
5
Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database.利用韩国国家健康信息数据库进行内分泌疾病的大数据研究。
Endocrinol Metab (Seoul). 2023 Feb;38(1):10-24. doi: 10.3803/EnM.2023.102. Epub 2023 Feb 9.
6
Bariatric surgery trends and progress in Taiwan: 2010-2021.台湾地区减重手术的趋势与进展:2010-2021 年。
Obes Res Clin Pract. 2023 Jan-Feb;17(1):66-73. doi: 10.1016/j.orcp.2022.12.004. Epub 2023 Jan 7.
7
Association between the Blautia/Bacteroides Ratio and Altered Body Mass Index after Bariatric Surgery.肥胖症手术后肠道菌 Blautia/Bacteroides 比值与体重指数改变的关系。
Endocrinol Metab (Seoul). 2022 Jun;37(3):475-486. doi: 10.3803/EnM.2022.1481. Epub 2022 Jun 29.
8
Obesity Fact Sheet in Korea, 2021: Trends in Obesity Prevalence and Obesity-Related Comorbidity Incidence Stratified by Age from 2009 to 2019.《2021年韩国肥胖情况说明书:2009年至2019年按年龄分层的肥胖患病率和肥胖相关合并症发病率趋势》
J Obes Metab Syndr. 2022 Jun 30;31(2):169-177. doi: 10.7570/jomes22024.
9
The Influence of Obesity and Metabolic Health on Vascular Health.肥胖和代谢健康对血管健康的影响。
Endocrinol Metab (Seoul). 2022 Feb;37(1):1-8. doi: 10.3803/EnM.2022.101. Epub 2022 Feb 28.
10
East Asian perspectives in metabolic and bariatric surgery.代谢与减重外科学的东亚视角。
J Diabetes Investig. 2022 May;13(5):756-761. doi: 10.1111/jdi.13748. Epub 2022 Feb 4.